U.S. Medical Equipment Stock News

IDACORP, Inc. reported past first-quarter 2026 results showing sales of US$402.76 million and net income of US$67.98 million, with diluted EPS from continuing operations of US$1.21, up from US$1.10 a year earlier. Alongside reaffirming its full-year 2026 earnings guidance of US$6.25 to US$6.45 per diluted share, the company expects Idaho Power to use less than US$30 million of additional tax credits under its Idaho regulatory mechanism, assuming normal weather and power supply expenses. We...

In recent months, multiple law firms have launched securities class action lawsuits against Power Solutions International, alleging false and misleading statements about its ability to meet data center sales demand and manage related manufacturing costs between May 2025 and March 2026. The wave of similar complaints highlights how disclosures about operational inefficiencies and gross margin pressure can rapidly shift legal, operational, and governance risks for shareholders. Next, we’ll...

In early May 2026, Supernus Pharmaceuticals, Inc. reported first-quarter 2026 results showing revenue of US$207.71 million versus US$149.82 million a year earlier, with net loss narrowing to US$2.29 million from US$11.83 million. On the same day, the company reiterated its full-year 2026 outlook, projecting total revenues of US$840 million–US$870 million and operating earnings of US$0–US$30 million, signalling management’s confidence in its current trajectory. We’ll now examine how...

Winmark (WINA) is in focus after the company outlined upcoming board changes, with long-serving director Lawrence A. Barbetta set to step down and marketing executive Stephanie S. Hoppe joining the board. See our latest analysis for Winmark. The board changes arrive after a softer run for the stock, with a 30-day share price return of a 13.0% decline and a 90-day share price return of an 18.7% decline. The 5-year total shareholder return of 120.1% points to much stronger longer term...

Q1 2026 earnings event reshapes the story Old Second Bancorp (OSBC) just posted Q1 2026 results that combine higher net income, a completed acquisition that expanded assets and footprint, and a clear rise in credit costs tied to problem loans. See our latest analysis for Old Second Bancorp. At a share price of $21.08, Old Second Bancorp has a year to date share price return of 8.21%. Its 1 year total shareholder return of 27.57% and 3 year total shareholder return of 95.98% point to momentum...

One of the biggest stories of last week was how Installed Building Products, Inc. ( NYSE:IBP ) shares plunged 25% in...

With inflation readings still elevated in many countries, bond yields reacting to every policy hint and trade flows shifting across regions, it is easy to feel stuck on the sidelines. One way to cut through the noise is to focus on founder-led companies where leadership has real skin in the game and capital is used carefully. This screener does exactly that, filtering for businesses where founders are still in charge and closely aligned with shareholders. In this article, you will see three...

Donnelley Financial Solutions recently reported first-quarter 2026 results showing revenue of US$205.5 million and net income of US$33.5 million, with earnings per share rising year on year. The company also issued second-quarter sales guidance and highlighted growing demand for its software platforms as clients adapt to evolving SEC reporting rules. Now we will examine how this earnings update and softer revenue guidance may influence Donnelley Financial Solutions’ existing investment...

Incyte Corporation ( NASDAQ:INCY ) announced strong profits, but the stock was stagnant. We did some digging, and we...

We wouldn't blame Intel Corporation ( NASDAQ:INTC ) shareholders if they were a little worried about the fact that...

Key earnings takeaways for Surgery Partners (SGRY) Surgery Partners (SGRY) kicked off 2026 with first quarter results that paired revenue growth with a narrower loss, while management reaffirmed full year guidance and highlighted ongoing cost discipline and portfolio work. The company reported Q1 revenue of US$810.9 million, basic and diluted loss per share from continuing operations of US$0.28, and an overall net loss of US$35.9 million. Management reiterated full year 2026 revenue guidance...

National Storage Affiliates Trust recently reported past first quarter 2026 results, with revenue of US$185.4 million and net income rising to US$17.78 million, lifting diluted earnings per share from continuing operations to US$0.16. Alongside this, an updated filing showed Prudential Financial and its subsidiaries collectively hold about 1.8% of the company’s common stock, highlighting continuing institutional interest in the self-storage REIT. With higher earnings per share despite...

If you are wondering whether Harmonic at US$12.28 is offering fair value or an opportunity, you will want to look past the headline share price and into what the valuation signals are really saying. The stock has recently shown sharp moves, with returns of 7.4% over the past week, 30.9% over the last 30 days, 22.6% year to date and 35.2% over the past year, set against a 22.8% decline over 3 years and a 78.2% gain over 5 years. Recent coverage around Harmonic has focused on its role as a...

Wondering whether Silicon Motion Technology's current share price matches its underlying worth, or if expectations have simply raced ahead of fundamentals. The stock last closed at US$242.71, with returns of 10.9% over 7 days, 107.4% over 30 days, 158.9% year to date and 368.2% over the past year. This puts valuation questions front and center. Recent coverage has focused on the stock's sharp gains and what they might signal about investor confidence and changing risk perception. This kind...

Wilson Bank Holding (WBHC) opened 2026 with Q1 revenue of US$60.8 million and basic EPS of US$1.82, while trailing 12 month revenue stood at US$229.8 million and EPS was US$6.73, supported by earnings growth of 35.6% over the past year. Over recent periods the company has seen revenue move from US$181.7 million and EPS of US$4.79 on a trailing 12 month basis at Q4 2024 to US$219.9 million and EPS of US$6.28 by Q4 2025. This sets up the latest quarter against a track record of expanding profit...

Hill York Service, an EMCOR Group subsidiary, has been selected as the official HVAC partner for Inter Miami CF's new Nu Stadium. The agreement covers HVAC systems for the new venue and aligns EMCOR with a high profile sports facility project. This development adds a fresh angle to the EMCOR story beyond recent attention on quarterly results and guidance. For investors tracking EMCOR Group (NYSE:EME), the Hill York Service partnership with Inter Miami CF comes on top of a stock that has...

Backblaze (BLZE) drew fresh attention after first quarter 2026 results, with revenue of US$38.67 million and a net loss of US$6.15 million, alongside higher full year revenue guidance. See our latest analysis for Backblaze. The beat and raise has been met with sharp buying interest, with Backblaze’s share price at US$7.50 and a 30 day share price return of 107.18%, while the 1 year total shareholder return sits at 42.86%. This suggests strong recent momentum on expectations for AI related...

Amylyx Pharmaceuticals (NasdaqGS:AMLX) is advancing avexitide through the pivotal Phase III LUCIDITY trial for post-bariatric hypoglycemia (PBH). Pivotal Phase III data from LUCIDITY are expected next quarter. The company has also started a U.S. expanded access program so certain PBH patients can receive avexitide before any potential approval. Amylyx Pharmaceuticals focuses on therapies for serious neurological and metabolic conditions, with avexitide as its lead candidate for PBH. PBH can...

TSS, Inc. reported past first-quarter 2026 results with revenue of US$55.35 million and net income of US$2.28 million, down from US$98.96 million and US$2.98 million a year earlier, alongside lower earnings per share. Despite lower headline revenue, management highlighted strong AI-driven systems integration activity, maintained its full-year adjusted EBITDA outlook, and reinforced its AI infrastructure focus with senior hires in strategy and technology. We’ll now examine how this AI-fueled...

For investors wondering whether Fluor stock still offers value after a strong run, or if most of the opportunity is already priced in, this article focuses squarely on what you are paying versus what you are getting. Fluor recently closed at US$51.08, with returns of 7.0% over 30 days, 22.5% year to date and 43.4% over 1 year. This puts its longer term 3 year and 5 year returns at 93.0% and 169.8% respectively. Recent coverage has highlighted Fluor's role as a large engineering and...

If you are wondering whether BellRing Brands' current share price offers value or just more volatility, it helps to start with what the recent returns are actually telling you. The stock last closed at US$10.46, with returns of a 41.2% decline over 7 days, a 33.2% decline over 30 days, a 59.9% decline year to date and an 83.1% decline over the past year. This clearly changes how many investors think about its potential and its risks. Recent coverage has focused on how the company fits into...

BXP (NYSE:BXP) is relocating its regional headquarters to make room for major tenant the Washington Commanders in Foggy Bottom. The company is moving into a newly renovated downtown Washington, DC office building as part of this shift. The relocation aligns with recent leasing activity and capital deployment in the DC market. For investors watching NYSE:BXP, this move ties directly to how the company is using its portfolio to support active leasing and tenant relationships. The stock last...

Inovio Pharmaceuticals recently announced plans to release its Q1 2026 earnings after market close on May 13, 2026, alongside a conference call and upcoming scientific presentations on its DNA medicine pipeline for HPV-related diseases, cancer, and infectious diseases. Investor attention has intensified as Inovio’s DNA vaccine and gene transfer programs gain visibility, supported by significant institutional ownership and new clinical data disclosures on candidates such as INO-3107 and its...

Kestrel Group (KG) has wrapped up FY 2025 with fourth quarter revenue of US$10.2 million and a basic EPS loss of US$2.13, alongside net income from ongoing operations of a US$16.5 million loss and a US$1.4 million loss from discontinued operations. Over recent periods the company has seen quarterly revenue move from US$1.22 million in Q4 2024 to US$17.4 million in Q3 2025 and then US$10.2 million in Q4 2025. Basic EPS shifted from a small profit of US$0.02 in Q4 2024 to a sizeable profit of...